Breast Cancer Health Center
Breast Cancer and the Minimally Invasive Breast Biopsy
When a breast biopsy is recommended to test for breast cancer, patients may be able to choose a minimally invasive alternative to surgery known as image-guided needle biopsy. This is a technique that does not require surgery. Most of the time, the radiologist performs this type of biopsy.
How Is This Type Of Breast Biopsy Performed?
The needle breast biopsy can be performed using ultrasound or stereotactic guidance. Stereotactic refers to the use of stereo images -- pictures of the breast taken from different angles -- to determine the precise location of the abnormal tissue.
When stereotactic guidance is used, the patient lies on her abdomen on a specially designed exam table. An opening in the table allows access to the breast. The table is raised and the biopsy is done from below the table. This procedure may also be done with the patient sitting upright in a chair -- particularly for those who are unable to lie on their abdomen for any reason. When ultrasound guidance is used, the patient lies on her back on the exam table.
The area that needs to be tested is centered in the window of a specially designed compression paddle. Mammogram films are taken so the radiologist can examine the breast tissue to be biopsied. These films are called SCOUT films.
After giving a local anesthetic, the radiologist makes a small opening in the skin. A sterile biopsy needle is placed into the abnormal breast tissue. Computerized pictures help confirm the exact needle placement using digital imaging.
Tissue samples are taken through the needle. It is common to take about three to five tissue samples. There are a number of biopsy instruments that can be utilized to obtain the tissue sample. They include core biopsy which uses a needle to obtain a piece of tissue about 1/16 inch across and ½ inch long, and a vacuum assisted needle biopsy device (VAD), which uses vacuum suction to obtain a tissue sample. This tissue is then examined under the microscope to look for cancer cells. This part of the biopsy takes approximately 15 minutes. Upon completion, sterile strips and a small adhesive bandage are applied to the skin. The entire procedure takes approximately 30 minutes to an hour. Results are usually available in three to five working days.
What Are The Benefits Of Minimally Invasive Biopsy?
Minimally invasive biopsy offers:
- Minimal scarring instead of a large incision.
- Reduced pain and risk of infection after the procedure.
- Potentially lower hospital costs.
- Immediate return to work.
- Shorter recovery time and immediate resumption of daily activities.
How Safe Is Minimally Invasive Biopsy?
Minimally invasive breast biopsy is as safe as "open" surgery when performed by breast imaging specialists in this field.
WebMD Medical Reference
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.

